Project Details
Description
Epidemiological studies consistently demonstrate that HSV-2 adversely impacts HIV. Defining the
underlying mechanisms will lead to the development of new strategies for HIV eradication. We propose
to test the hypothesis that HSV-2 promotes changes in peripheral blood CD4+ T cells that facilitate
HIV reactivation and to identify pathways and molecules that could be targeted to block HIV
reactivation in response to HSV-2 or conversely, enhance latency reversal as part of “shock and kill”
HIV eradication strategies.
Status | Finished |
---|---|
Effective start/end date | 12/5/17 → 11/30/22 |
Funding
- National Institute of Allergy and Infectious Diseases: $483,050.00
- National Institute of Allergy and Infectious Diseases: $488,089.00
- National Institute of Allergy and Infectious Diseases: $494,568.00
- National Institute of Allergy and Infectious Diseases: $518,436.00
- National Institute of Allergy and Infectious Diseases: $509,551.00
- National Institute of Allergy and Infectious Diseases: $2,743.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.